Biopharma AI
By
Inductive Bio and Amgen Collaborate With ARPA-H to Advance AI-Based Alternatives to Animal Toxicology Testing
United States Inductive Bio, a New York–based artificial intelligence company focused on drug discovery, has been awarded up…
Pfizer Celebrates Innovation with 2025 AI Festival
Global – Pfizer hosted its second annual AI Festival Week, bringing together colleagues worldwide to explore the transformative…
Bristol Myers Squibb Unveils “Mosaic” AI Content Hub in Mumbai, Advancing Tech-Enabled Patient Engagement
Mumbai, India Bristol Myers Squibb (BMS) today announced the launch of Mosaic, a new artificial intelligence–enabled content hub…
Endpoints Signal Report Finds Nearly Half of Biopharma Professionals Are Heavy AI Users, With Expectations of Major R&D Transformation Ahead
Based on Endpoints Signal Pulse Report | December 2025 A new Signal Pulse Report from Endpoints News reveals…
Is AI Now Shaping the Future of Biopharma R&D — and Who’s Leading the Transformation?
Executive Summary A recent Endpoints Signal Pulse Report reveals that half of biopharma professionals now consider themselves heavy…
Did NVIDIA Become the Central AI Catalyst for Biopharma in 2025—And Which Players Benefited Most?
2025 marked a pivotal year for artificial intelligence in biopharma. As life sciences companies moved beyond isolated AI…
